Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
IGC Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2025 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q3 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q1 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q3 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2026 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q1 2027 | 1 | -$0.03 | -$0.02 | -$0.03 |
IGC Pharma, Inc. Earnings Date And Information
IGC Pharma, Inc. last posted its earnings results on Thursday, August 14th, 2025. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.03 by $0.01. The company had revenue of 328.00 K for the quarter and had revenue of 1.27 M for the year. IGC Pharma, Inc. has generated $0 earnings per share over the last year ($-0.0931 diluted earnings per share) and currently has a price-to-earnings ratio of -5.39. IGC Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based on prior year's report dates.
IGC Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2025 | Q1 2026 | -$0.03 | -$0.02 | 0.01 | $326.00 K | $328.00 K |
| 06/27/2025 | Q4 2025 | -$0.02 | -$0.02 | 0 | N/A | $330.00 K |
| 02/14/2025 | Q3 2025 | -$0.03 | -$0.02 | 0.01 | N/A | $257.00 K |
| 11/12/2024 | Q2 2025 | -$0.02 | -$0.02 | -0.01 | $291.00 K | $412.00 K |
| 08/07/2024 | Q1 2025 | N/A | -$0.03 | N/A | $450.00 K | $272.00 K |
| 06/24/2024 | Q4 2024 | -$0.00 | -$0.04 | -0.04 | N/A | $295.00 K |
| 02/14/2024 | Q3 2024 | -$0.04 | -$0.09 | -0.05 | N/A | $204.00 K |
| 11/09/2023 | Q2 2024 | N/A | -$0.05 | N/A | N/A | $291.00 K |
| 08/10/2023 | Q1 2024 | N/A | -$0.04 | N/A | N/A | $555.00 K |
| 07/07/2023 | Q4 2023 | N/A | -$0.08 | N/A | N/A | $166.00 K |
| 02/14/2023 | Q3 2023 | N/A | -$0.04 | N/A | N/A | $332.00 K |
| 11/01/2022 | Q2 2023 | N/A | -$0.05 | N/A | N/A | $202.00 K |
| 08/05/2022 | Q1 2023 | N/A | -$0.05 | N/A | N/A | $212.00 K |
| 06/22/2022 | Q4 2022 | N/A | -$0.16 | N/A | N/A | $122.00 K |
| 02/10/2022 | Q3 2022 | N/A | -$0.05 | N/A | N/A | $142.00 K |
| 10/29/2021 | Q2 2022 | N/A | -$0.09 | N/A | N/A | $56.00 K |
| 08/11/2021 | Q1 2022 | N/A | -$0.04 | N/A | N/A | $77.00 K |
| 06/14/2021 | Q4 2021 | N/A | -$0.07 | N/A | N/A | $81.00 K |
| 02/12/2021 | Q3 2021 | N/A | -$0.06 | N/A | N/A | $108.00 K |
| 11/20/2020 | Q2 2021 | N/A | -$0.04 | N/A | N/A | $125.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IGC Pharma, Inc. Earnings: FAQ's
IGC Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based offlast year's report dates.
In the previous quarter, IGC Pharma, Inc. (:IGC) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.03 by $0.01.
The conference call for IGC Pharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for IGC Pharma, Inc.'s latest earnings report can be read online.
IGC Pharma, Inc. (:IGC) has a recorded annual revenue of $1.27 M.
IGC Pharma, Inc. (:IGC) has a recorded net income of $-7,121,000.IGC Pharma, Inc. has generated $-0.0931 earnings per share over the last four quarters.
IGC Pharma, Inc. (:IGC) has a price-to-earnings ratio of -5.39 and price/earnings-to-growth ratio is -0.38.